Microbiota modification in hematology: still at the bench or ready for the bedside?
Abstract: Growing evidence suggests that human microbiota likely influence diverse processes including hematopoiesis, chemotherapy metabolism, and efficacy, as well as overall survival in patients with hematologic malignancies and other cancers.Both host genetic susceptibility and host-microbiota interactions may impact cancer risk and response to